More R&D-heavy organizations in sectors like biopharma are revamping their data plumbing. One such entity is Moderna, which is expanding its collaboration with Benchling to consolidate fragmented laboratory data into a unified, AI-primed platform. This move addresses an industry gap, as a 2024 Benchling report found that only 14% of large biopharma and a 3%…